|
|
|
| Pulmonary opportunistic infection in AIDS |
| ZENG Jing LIU Xuemei HUA Wei GUO Caiping JIN Ronghua▲ ZHANG Yulin▲ |
| Department of Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China |
|
|
|
Abstract Pulmonary is a common target organ of opportunistic infection (OI) in acquired immune deficiency syndrome (AIDS), with a high incidence and mortality. The pathogenic spectrum of the pulmonary OI in AIDS is widespread, including bacteria, mycobacteria, fungi, viruses and parasites, and bacterial fungi, but the most common bacteria are bacterial, mycobacteria and fungi. There are certain characteristics in the clinical manifestation and the diagnosis and treatment. In this paper, the related characteristics of pulmonary OI in AIDS a reviewed, and hope is beneficial to the reader.
|
|
|
|
|
|
[1] Djawe K，Buchacz K，Hsu L，et al. Mortality risk after AIDS-defining opportunistic illness among HIV-infected persons—San Francisco，1981-2012 [J]. J Infect Dis，2015， 212（9）：1366-1375
[2] Andrea L，Georgios G，Natasha L，et al. Incidence of opportunistic infections and the impact of antiretroviral therapy among HIV-infected adults in low-and middle-income countries：a systematic review and meta-analysis [J]. Clin Infect Dis，2016，62（12）：1595-1603.
[3] Charles F，Ronald A. HIV-associated bacterial pneumonia [J]. Clin Chest Med，2013，34（2）：205-216.
[4] Aberg JA，Gallant JE，Ghanem KG，et al. Primary care guidelines for the management of persons infected with HIV：2013 update by the HIV Medicine Association of the Infectious Diseases Society of America [J]. Clin Infect Dis，2014，58（1）：1-10.
[5] Benson CA，Brooks JT，Holmes KK，et al. Guidelines for prevention and treatment opportunistic infections in HIV-infected adults and adolescents；recommendations from CDC，the National Institutes of Health，and the HIV Medicine Association/Infectious Diseases Society of America [J]. Aids in Adolescence，2009.
[6] Ledgerwood DM，Yskes R. Smoking cessation for people living with HIV/AIDS：a literature review and synthesis [J]. Nicotine Tob Res，2016，18（12）：2177-2184.
[7] Bruchfeld J，Correia-Neves M，Källenius G. Tuberculosis and HIV coinfection [J]. Cold Spring Harb Perspect Med，2015，5（7）：a017 871.
[8] Sterling TR，Pham PA，Chaisson RE. HIV infection—related tuberculosis：clinical manifestations and treatment [J]. Clin Infect Dis，2010，50（3）：223-230.
[9] Lewinsohn DM，Leonard MK，LoBue PA，et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines：diagnosis of tuberculosis in adults and children [J]. Clin Infect Dis，2017，64（2）：e1-e33.
[10] Nahid P，Dorman SE，Alipanah N，et al. Official American Thoracic Society/centers for disease control and prevention/infectious diseases society of America clinical practice guidelines：treatment of drug-susceptible tuberculosis [J]. Clin Infect Dis，2016，63（7）：e147-e195.
[11] 李亮，刘宇红，杜建.结核病诊疗进展年度回眸（2015年）[J].中华结核和呼吸杂志，2016，39（1）：5-7.
[12] Haileyesus G，Alberto M，Ibrahim A，et al. Management of latent mycobacterium tuberculosis infection：WHO guidelines for low tuberculosis burden countries [J]. Eur Respir J，2015，46（6）：1563-1576.
[13] 卫生部.中国结核病防治规划实施工作指南（2008年版）[M].北京：中国协和医科大学出版社，2009.
[14] Griffith DE，Aksamit T，Brown-Elliott BA，et al. An official ATS/IDSA statement：diagnosis，treatment，and prevention of nontuberculous mycobacterial diseases [J]. Am J Respir Crit Care Med，2007，175（4）：367-416.
[15] Huang L，Cattamanchi A，Davis JL，et al. HIV-associated pneumocystis pneumonia [J]. Proc Am Thorac Soc，2011， 8（3）：294-300.
[16] 王爱霞，王福生，王清玥，等.艾滋病诊疗指南[J].中华传染病杂志，2006，6（2）：133-144.
[17] Thoden J，Potthoff A，Bogner J，et al. Therapy and prophylaxis of opportunistic infections in HIV-infected patients：a guideline by the German and Austrian AIDS societies（DAIG/?魻AG）（AWMF055/066） [J]. Infection，2013， 41（2）：91-115.
[18] Marukutira T，Huprikar S，Azie N，et al. Clinical characteristics and outcomes in 303 HIV-infected patients with invasive fungal infections：data from the prospective antifungal therapy alliance registry，a multicenter，observational study [J]. HIV AIDS （Auckl），2014，6：39-47.
[19] Yu X，Shen J，Qu Y，et al. Radiological features of AIDS complicated by pulmonary cryptococcosis：Literature review and a report of 10 cases [J]. Radiology of Infectious Diseases，2016，3（1）：9-14.
[20] 曾能永，徐云欢，孔晋亮.肺隐球菌病诊治进展[J].国际呼吸杂志，2016，36（3）：218-223.
[21] International C. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection：recommendations for a public health approach [J]. Geneva Switzerland Who，2013.
[22] Hu Y，Zhang J，Li X，et al. Penicillium marneffei infection：an emerging disease in mainland China [J]. Mycopathologia，2013，175（1-2）：57-67.
[23] Wong SY，Wong K. Penicillium marneffei Infection in AIDS [J]. Patholog Res Int，2011（3）：764 293.
[24] Pupaibool J，Limper AH. Other HIV-associated pneumonias [J]. Clin Chest Med，2013，34（2）：243-254.
[25] Cambrea SC，Carp SD，Halichidis S. Disseminated toxoplasmosis in an HIV positive patient in cART era [J]. BMC Infect Dis，2014，14（4）：P41. |
|
|
|
